Cegedim Future Growth

Future criteria checks 4/6

Cegedim se prevé un crecimiento anual de los beneficios y los ingresos de 24.1% y 6.1%, respectivamente, mientras que el BPA aumentará de grow a 24.7%.

Key information

24.1%

Earnings growth rate

24.7%

EPS growth rate

Healthcare Services earnings growth	29.2%
Revenue growth rate	6.1%
Future return on equity	n/a
Analyst coverage	Low
Last updated	10 May 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:CGMP - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	673	29	36	N/A	3
12/31/2024	640	23	31	103	4
12/31/2023	611	19	24	93	4
12/31/2022	555	14	10	86	N/A
9/30/2022	548	14	-7	64	N/A
6/30/2022	541	15	-25	42	N/A
3/31/2022	533	21	3	69	N/A
12/31/2021	525	26	31	96	N/A
9/30/2021	518	24	36	106	N/A
6/30/2021	512	22	41	116	N/A
3/31/2021	504	16	39	113	N/A
12/31/2020	497	11	36	110	N/A
9/30/2020	496	10	28	98	N/A
6/30/2020	494	8	21	85	N/A
3/31/2020	499	5	-6	57	N/A
12/31/2019	504	3	-33	29	N/A
9/30/2019	495	-1	-8	54	N/A
6/30/2019	486	-5	18	80	N/A
3/31/2019	477	0	41	102	N/A
12/31/2018	468	4	65	124	N/A
9/30/2018	464	8	41	100	N/A
6/30/2018	461	12	18	77	N/A
3/31/2018	459	10	16	75	N/A
12/31/2017	457	7	13	73	N/A
9/30/2017	452	-13	19	82	N/A
6/30/2017	438	-17	15	78	N/A
3/31/2017	435	-12	14	76	N/A
12/31/2016	429	-29	-3	59	N/A
9/30/2016	438	13	N/A	52	N/A
6/30/2016	435	9	N/A	55	N/A
3/31/2016	432	1	N/A	9	N/A
12/31/2015	426	19	N/A	40	N/A
9/30/2015	364	0	N/A	89	N/A
6/30/2015	380	-6	N/A	62	N/A
3/31/2015	399	-4	N/A	130	N/A
12/31/2014	412	-8	N/A	127	N/A
9/30/2014	161	-26	N/A	132	N/A
6/30/2014	266	-11	N/A	163	N/A
3/31/2014	377	-5	N/A	143	N/A
12/31/2013	488	-14	N/A	150	N/A
9/30/2013	906	21	N/A	131	N/A
6/30/2013	904	4	N/A	130	N/A
3/31/2013	931	-92	N/A	128	N/A
12/31/2012	922	-85	N/A	117	N/A
9/30/2012	913	-103	N/A	106	N/A
6/30/2012	908	-87	N/A	131	N/A

Analyst Future Growth Forecasts

Ingresos vs. tasa de ahorro: CGMP(24.1% al año) es superior a la tasa de ahorro (1.2%).

Beneficios frente mercado: CGMPSe prevé que los beneficios de la empresa (24.1% al año) crezcan más deprisa que el mercado UK (10.3% al año).

Beneficios de alto crecimiento: CGMPSe espera que los beneficios de la empresa crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: CGMPSe prevé que los ingresos de la empresa (6.1% al año) crezcan más deprisa que los del mercado UK (4% al año).

Ingresos de alto crecimiento: CGMPSe prevé que los ingresos de la empresa (6.1% al año) crezcan más despacio que 20% al año.

Earnings per Share Growth Forecasts

Future Return on Equity

Futura rentabilidad financiera (ROE): Datos insuficientes para determinar si la Rentabilidad de los fondos propios de CGMP se prevé elevada dentro de 3 años.

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Cegedim Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Cegedim Provides Revenue Guidance for the Full Year 2023

Cegedim SA Provides Revenue Guidance for the Full Year 2023

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Cegedim Provides Revenue Guidance for 2022

Cegedim SA Provides Revenue Guidance for the Year 2022

Recent updates

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

Cegedim Provides Revenue Guidance for the Full Year 2023

Cegedim SA Provides Revenue Guidance for the Full Year 2023

Less than half of directors are independent

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Cegedim SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Cegedim Provides Revenue Guidance for 2022

Less than half of directors are independent

Less than half of directors are independent

Cegedim SA (ENXTPA:CGM) acquired Merito, SAS.

Less than half of directors are independent

Less than half of directors are independent

Full year 2021 earnings released: EPS: €1.90 (vs €0.78 in FY 2020)

Less than half of directors are independent

Cegedim, Malakoff Humanis, Groupe VYV, PRO BTP in Talks for Acquisition of Equity Stake in Cegedim Santé

Cegedim SA Provides Revenue Guidance for the Year 2022

Cegedim SA to Report First Half, 2022 Results on Sep 20, 2022

Less than half of directors are independent

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies